Comparative dynamic aerosol efficiencies of three emergent coronaviruses and the unusual persistence of SARS-CoV-2 in aerosol suspensions

The emergent coronavirus, designated severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), is a zoonotic pathogen that has demonstrated remarkable transmissibility in the human population and is the etiological agent of a current global pandemic called COVID-19. We measured the dynamic (short-term) aerosol efficiencies of SARS-CoV-2 and compared the efficiencies with two other emerging coronaviruses, SARS-CoV (emerged in 2002) and Middle Eastern respiratory syndrome CoV (MERS-CoV; emerged starting in 2012). We also quantified the long-term persistence of SARS-CoV-2 and its ability to maintain infectivity when suspended in aerosols for up to 16 hours.

[1]  B. Meyers,et al.  The emergence , evolution , and diversification of the miR 390-TAS 3-ARF pathway in land plants , 2016 .

[2]  Dylan H. Morris,et al.  Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1 , 2020, The New England journal of medicine.

[3]  Jun Zheng.  SARS-CoV-2: an Emerging Coronavirus that Causes a Global Threat , 2020, International journal of biological sciences.

[4]  Vineet D. Menachery,et al.  Severe Acute Respiratory Syndrome Coronavirus 2 from Patient with Coronavirus Disease, United States , 2020, Emerging infectious diseases.

[5]  James O. Lloyd-Smith,et al.  Aerosol and surface stability of HCoV-19 (SARS-CoV-2) compared to SARS-CoV-1 , 2020, medRxiv.

[6]  Zheng Zhao,et al.  Investigation of three clusters of COVID-19 in Singapore: implications for surveillance and response measures , 2020, The Lancet.

[7]  Malik Peiris,et al.  Molecular Diagnosis of a Novel Coronavirus (2019-nCoV) Causing an Outbreak of Pneumonia , 2020, Clinical chemistry.

[8]  K. O’Malley,et al.  Development, Characterization, and Standardization of a Nose-Only Inhalation Exposure System for Exposure of Rabbits to Small-Particle Aerosols Containing Francisella tularensis , 2019, Infection and Immunity.

[9]  Robert H. Gilman,et al.  Dynamics of Cough Frequency in Adults Undergoing Treatment for Pulmonary Tuberculosis , 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[10]  Jonathan V. Szalajda,et al.  A Cough Aerosol Simulator for the Study of Disease Transmission by Human Cough-Generated Aerosols , 2013, Aerosol science and technology : the journal of the American Association for Aerosol Research.

[11]  D. Verreault,et al.  Susceptibility of monkeypox virus aerosol suspensions in a rotating chamber , 2012, Journal of virological methods.

[12]  Benjamin J. Cowling,et al.  Influenza Virus Aerosols in Human Exhaled Breath: Particle Size, Culturability, and Effect of Surgical Masks , 2010, Occupational and Environmental Medicine.

[13]  D. Reed,et al.  Infectious disease aerobiology: miasma incarnate , 2012, Front. Cell. Inf. Microbio..

[14]  M. Chatigny,et al.  The use of a rotating drum for the study of aerosols over extended periods of time. , 1958, American journal of hygiene.